These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Infrequent occurrence of single mutations in topoisomerase IV and DNA gyrase genes among US levofloxacin-susceptible clinical isolates of Streptococcus pneumoniae from nine institutions (1999-2003). Davies TA, Yee YC, Goldschmidt R, Bush K, Sahm DF, Evangelista A. J Antimicrob Chemother; 2006 Mar; 57(3):437-42. PubMed ID: 16431861 [Abstract] [Full Text] [Related]
4. Are fluoroquinolone-susceptible isolates of Streptococcus pneumoniae really susceptible? A comparison of resistance mechanisms in Canadian isolates from 1997 and 2003. Schurek KN, Adam HJ, Siemens CG, Hoban CJ, Hoban DJ, Zhanel GG. J Antimicrob Chemother; 2005 Oct; 56(4):769-72. PubMed ID: 16126779 [Abstract] [Full Text] [Related]
5. The molecular epidemiology of Streptococcus pneumoniae with quinolone resistance mutations. Richter SS, Heilmann KP, Beekmann SE, Miller NJ, Rice CL, Doern GV. Clin Infect Dis; 2005 Jan 15; 40(2):225-35. PubMed ID: 15655739 [Abstract] [Full Text] [Related]
6. Emergence and epidemiology of fluoroquinolone-resistant Streptococcus pneumoniae strains from Italy: report from the SENTRY Antimicrobial Surveillance Program (2001-2004). Deshpande LM, Sader HS, Debbia E, Nicoletti G, Fadda G, Jones RN, SENTRY Antimicrobial Surveillance Program (2001-2004). Diagn Microbiol Infect Dis; 2006 Mar 15; 54(3):157-64. PubMed ID: 16423493 [Abstract] [Full Text] [Related]
7. Emergence of a fluoroquinolone-resistant strain of Streptococcus pneumoniae in England. Johnson AP, Sheppard CL, Harnett SJ, Birtles A, Harrison TG, Brenwald NP, Gill MJ, Walker RA, Livermore DM, George RC. J Antimicrob Chemother; 2003 Dec 15; 52(6):953-60. PubMed ID: 14585858 [Abstract] [Full Text] [Related]
8. Mutant prevention concentrations for single-step fluoroquinolone-resistant mutants of wild-type, efflux-positive, or ParC or GyrA mutation-containing Streptococcus pneumoniae isolates. Smith HJ, Walters M, Hisanaga T, Zhanel GG, Hoban DJ. Antimicrob Agents Chemother; 2004 Oct 15; 48(10):3954-8. PubMed ID: 15388458 [Abstract] [Full Text] [Related]
14. [Fluoroquinolone resistance determining region mutation in Streptococcus pneumonia isolates]. Zhang FF, Zhao CJ, Wang H. Zhonghua Jie He He Hu Xi Za Zhi; 2013 Dec 15; 36(12):940-4. PubMed ID: 24503427 [Abstract] [Full Text] [Related]
18. In vitro selection of resistance in Streptococcus pneumoniae at in vivo fluoroquinolone concentrations. De Vecchi E, Nicola L, Ossola F, Drago L. J Antimicrob Chemother; 2009 Apr 15; 63(4):721-7. PubMed ID: 19218275 [Abstract] [Full Text] [Related]
19. Antimicrobial resistance among Streptococcus pneumoniae in the United States: have we begun to turn the corner on resistance to certain antimicrobial classes? Doern GV, Richter SS, Miller A, Miller N, Rice C, Heilmann K, Beekmann S. Clin Infect Dis; 2005 Jul 15; 41(2):139-48. PubMed ID: 15983908 [Abstract] [Full Text] [Related]
20. Cross-resistance, relatedness and allele analysis of fluoroquinolone-resistant US clinical isolates of Streptococcus pneumoniae (1998-2000). Davies TA, Goldschmidt R, Pfleger S, Loeloff M, Bush K, Sahm DF, Evangelista A. J Antimicrob Chemother; 2003 Aug 15; 52(2):168-75. PubMed ID: 12837740 [Abstract] [Full Text] [Related] Page: [Next] [New Search]